Trial ID or NCT#
The purpose of this trial is to assess the efficacy and safety of Xyrem in pediatrics subjects with narcolepsy that includes cataplexy.
Ages Eligible for Study: 7 Years to 17 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: No
Chad Ruoff, MD
Contact us to find out if this trial is right for you.